• Icon International Neuroendocrine Cancer Alliance

  • Mail: post@incalliance.org

Tag: Paraganglioma

IMG_3424
PRRT trials for pheo/para patients have begun at the National Cancer Institute in Washington, D.C.

The Pheo Para Alliance announced that PRRT trials for pheo/para patients have begun at the National Cancer Institute, a division of the National Institutes of Health in Washington, D.C. More information on this important clinical trial can be found here. The alliance, which was formed by the merger of the Pheo Para Alliance and the…

Read More
Copyright © 2015 International Neuroendocrine Cancer Alliance. All right reserved.
Make a Donation
Paybal button